BOSTON--(BUSINESS WIRE)--Elucid has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its PlaqueIQ™ imaging analysis software to help physicians diagnose ...
A new system that uses artificial intelligence (AI) to assess cardiovascular risk based on images of the eye captured during ...
An AI algorithm based only on routine mammogram images plus age can predict a woman's risk of major cardiovascular disease as well as standard risk assessment methods, finds research published online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results